Redag doubles size of team

Pioneering agrochemicals company Redag Crop Protection has more than doubled the size of its team after a successful fundraising earlier this year.

Alderley Park-based Redag creates crop protection products for the agrochemical industry from the Cheshire life science complex. The company has seen major growth opportunities in the sector and is now expecting to complete the line-up of its senior team this summer.

Among the senior recruits is highly experienced commercial director Dr Andy Jones. Jones’ career includes senior roles with Astra Zeneca’s crop protection business and consultants CapGemini Ernst & Young in their life sciences practice. He then joined and floated a life sciences business on the AIM market, before moving to Arysta Lifesciences, a crop protection business with annual sales in excess of $1.2bn, where he was initially chief executive for Europe and then head of global marketing and R&D.

See the article in full at ManchesterEveningNews.co.uk

Important information

This information is of a general nature and does not constitute an offer to provide services.

The opinions and conclusions given here are those of Seneca Partners and are subject to change without notice.

The value of investments and/or any income arising from them may fluctuate.

Past performance is not necessarily a guide to future performance.

Important notice

The products and services shown on this website place capital at risk. Investors may receive less in returns than they have invested. Investments may not allow for capital to be withdrawn on demand. If an investment provides tax relief then this relief is subject to change and is dependant on personal circumstances. Any reference to past performance or forecasted performance is not a reliable indicator of future performance.

Seneca Partners recommends that any investor seeks specialised financial and/or tax advice before investing. Seneca Partners does not provide advice and the information on this website, including but not limited to news, should not be construed as such.

Please confirm that you understand this warning and wish to proceed.